Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (symbol: HUM) is a leading private health insurer in the United States, with a primary focus on Medicare Advantage plans. The company has carved out a significant niche in the healthcare market by specializing in government-sponsored programs. Nearly all of Humana's medical memberships come from individual and group Medicare Advantage plans, Medicaid, and the military's Tricare program. This makes it a pivotal player in providing health insurance solutions to a diverse segment of the population.
In addition to its core insurance offerings, Humana is a frontrunner in stand-alone prescription drug plans, particularly for seniors enrolled in traditional fee-for-service Medicare. This is part of their broader commitment to ensuring comprehensive healthcare accessibility for all members.
Humana continuously strives to innovate and improve its services, recognizing that healthcare needs are dynamic and vary among individuals, families, and communities. The company's cultural foundation is deeply rooted in helping members achieve optimal health by delivering personalized and simplified healthcare experiences. Their array of services includes not only medical insurance but also primary-care services, at-home healthcare services, and pharmacy benefit management.
The company's recent achievements and current projects reflect its commitment to holistic health solutions. Through CenterWell, Humana provides the latest updates and resources aimed at helping people live their healthiest lives on their terms, whenever and wherever they need it.
Humana's employees are central to its mission. The company has built an organization of dynamic talent, whose experience and passion are focused on putting the customer first. This dedication is evident in their innovative approach to healthcare, which continuously adapts to meet evolving needs.
With its strong financial condition and strategic partnerships, Humana is well-positioned to continue its leadership in the healthcare industry. Whether you are an investor looking for reliable stock performance or a member seeking high-quality healthcare services, Humana remains a standout choice.
Humana Healthy Horizons, the Medicaid division of Humana Inc. (NYSE: HUM), contributed over $1 million to Louisiana non-profits in the past year, supporting initiatives focused on health, housing, education, and food security. Among the recipients are organizations like the American Heart Association and Access Health Louisiana. Regional President Lori Dunne emphasized the company's commitment to improving community health. Humana serves over 437,000 Louisianans through various healthcare programs and has been selected to manage Medicaid for beneficiaries in the state starting in 2023.
Humana Inc. (NYSE: HUM) has successfully completed a public offering of $1.25 billion in senior notes. This includes $500 million of 5.700% notes maturing in 2026 and $750 million of 5.500% notes maturing in 2053. The anticipated net proceeds amount to approximately $1.211 billion, primarily to repay a $500 million Delayed Draw Term Loan. Any excess funds will be allocated for general corporate purposes. A cautionary statement highlights potential risks associated with Humana's financial health, strategic initiatives, and regulatory compliance amidst ongoing challenges posed by the COVID-19 pandemic.
An independent analysis from Florida State University reveals that Humana Inc. (NYSE: HUM) significantly impacts Florida's economy, contributing approximately
Humana Inc. (NYSE: HUM) has been recommended by the Indiana Family and Social Services Administration to receive a contract for the Medicaid Managed Long Term Services and Supports (MLTSS) program in Indiana, beginning in 2024. This contract allows Humana to expand its services, already supporting nearly 350,000 members in the state through various health plans. The initiative emphasizes a person-centered approach, leveraging technology and data analytics to enhance health outcomes and address disparities. The contract's initial term is four years, with options for renewal, allowing Humana to continue serving dually eligible Medicaid and Medicare members.
Humana Inc. (NYSE: HUM) and Aledade have announced a 10-year partnership aimed at enhancing value-based primary care for Medicare Advantage members. This collaboration builds on a successful relationship since 2019, which resulted in a 5% reduction in hospitalizations and 12% decrease in readmissions. By 2022, over 100,000 patients benefited from this value-based approach. The partnership will gradually expand through existing and new agreements, focusing on comprehensive care and risk sharing. Aledade aims to empower independent practices with technology and support, having generated over $1.2 billion in healthcare savings to date.
AM Best has assigned a Long-Term Issue Credit Rating of bbb- (Good) to Humana's recent $500 million, 5.7% senior unsecured notes due March 13, 2026 and $750 million, 5.5% senior unsecured notes due March 15, 2053. The outlook for these ratings is stable. The issuance aims to replace existing term loans, pre-fund upcoming maturities, and support general corporate purposes. Humana's financial leverage was approximately 42% as of Dec. 31, 2022, which is expected to moderate to about 40% long-term. Despite elevated leverage, earnings before interest and taxes coverage remains strong at over 10 times.
Humana Inc. (NYSE: HUM) announced a public offering of $1.25 billion in senior notes, comprised of $500 million due 2026 and $750 million due 2053. Pricing was set at 99.984% and 96.431% of the principal amount respectively. The offering is expected to close on March 13, 2023. Net proceeds, estimated at $1.211 billion, will repay a $500 million Delayed Draw Term Loan and cover general corporate purposes. The company is also vulnerable to various financial risks and regulatory changes, impacting profitability and operations, particularly due to its heavy government contract reliance.
Humana Inc. (NYSE: HUM) has announced that President and CEO Bruce D. Broussard will present to investors at the Cowen Health Care Conference on Tuesday, March 7, 2023, at 9:10 a.m. Eastern time. Investors can access a live audio webcast of the presentation on Humana's Investor Relations page, with a recommendation to log in 15 minutes early for system testing.
Humana is dedicated to improving health and well-being for its medical and specialty members while lowering costs. The company offers various clinical capabilities, including in-home care, behavioral health, and wellness solutions, aiming to simplify health care navigation for patients.
Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.885 per share, an increase of 12.4% from the previous $0.7875. The dividend is payable on April 28, 2023 to stockholders of record as of March 31, 2023. This reflects Humana's commitment to providing value to its shareholders while supporting integrated healthcare solutions. The company focuses on improving healthcare quality through in-home care, behavioral health, pharmacy services, and data analytics. Additional information is available on Humana's investor relations page.
FAQ
What is the current stock price of Humana (HUM)?
What is the market cap of Humana (HUM)?
What is Humana Inc.'s primary focus?
What types of healthcare services does Humana provide?
Who are Humana's primary members?
How does Humana innovate in healthcare delivery?
What is CenterWell?
Why is Humana a significant player in healthcare?
How does Humana support its mission through its employees?
What sets Humana apart from other health insurers?
What recent achievements has Humana made?
How does Humana's cultural foundation influence its operations?
